www.sigmaaldrich.com/stemcell |
|
Fibroblast Growth Factor 18 (FGF18)The human FGF18 (map locus: Entrez/HGNC: 5q34, Whitmore TE, et al. (2000); Ensembl: 5q35.1) gene product, fibroblast growth factor-18/FGF18, is a 207 AA long precursor protein that is cleaved to mature 180 AA FGF18 by removal of a 27 AA signaling sequence. FGF18 has two potential N-linked glycosylation sites, Asn39 and Asn137. Within the FGF family, FGF18 is most similar to FGF8 and FGF17, Maruoka Y, et al. (1998). FGF8, FGF17 and FGF18 compose an FGF subfamily that is involved in embryo development. The role of FGF18 in embryogenesis and post-natal development has been reviewed recently, Haque T, et al. (2007). FGF18 is a pleiotrophic growth factor involved in the development of early embryonic as well as adult tissues. FGF18 is present at high levels in trophoblast stem (TS) cells and preimplantation embryos, Zhong W, et al. (2006). It is also found in the isthmus organizer within the midbrain hindbrain boundary (MHB), Ohuchi H, et al. (2000); early cortical neurons, Hasegawa H, et al. (2004), embryonic lung tissue, Usui H, et al. (2004) and limb bud mesenchyme, Davidson D, et al. (2005). FGF18 is expressed in hair follicles, Kawano M, et al. (2005). Fgf18 is expressed in osteogenic mesenchymal cells and differentiating osteoblasts during calvarial bone development and in perichondrium of developing long bones, Ohbayashi N, et al. (2002), Liu Z et al. (2002). FGF18 may be an early marker for colorectal carcinoma, Shimokawa T, et al. (2003). Its expression is up-regulated in colorectal tumors and exerts pro-tumorigenic effects in both epithelial and stromal compartments as a survival factor, Sonvilla G, et al. (2008). FGF18 has been studied most extensively as a factor involved in endochondral bone development (endochondral ossification) through regulation of both chondrogenesis and osteogenesis, Ohbayashi N, et al. (2002). It is a trophic factor for mature chondrocytes and their progenitors, Ellsworth JL, et al. (2002) and a positive regulator of osteogenesis, Beak JY, et al. (2007). FGF18 negatively regulates chondrogenesis through fibroblast growth factor receptor 3 (FGFR3) and positively regulates osteogenesis through other FGF receptors. Binding of FGF18 to FGFR3 regulates proliferation, differentiation and matrix formation by articular and growth plate chondrocytes. FGFR3 inhibits chondrocyte proliferation, Wang Q, et al. (2001). FGF18 suppresses mesenchyme cell (chondrocyte progenitor) proliferation and promotes differentiation to chondrocytes and production of cartilage matrix. Davidson D, et al. (2005). FGF18 signaling through FGF receptor 3 may be an important target for therapeutic intervention to address degenerative disorders of cartilage metabolism such as osteoarthritis (OA) and achondroplasia, Moore EE, et al. (2005) and Valverde-Franco G, et al. (2006). Sigma offers antibodies and shRNAs useful for the study of FGF18 gene products.. References:
Footnote: Gene Data Sources: HGNC, Entrez Gene, UniProt/Swiss-Prot, UniProt/TrEMBL, GDB, OMIM, GeneLoc, Ensembl.
|
||||||||||||||||||||